Ignite Creation Date:
2025-12-24 @ 12:36 PM
Ignite Modification Date:
2026-05-30 @ 7:39 PM
Study NCT ID:
NCT04354961
Status:
UNKNOWN
Last Update Posted:
2023-11-08
First Post:
2020-04-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Almonertinib as First-line Treatment in Patients With EGFR+ Positive Pulmonary Adenosquamous Carcinoma or Combined Adenocarcinoma and Squamous Cell Carcinoma
Sponsor:
Organization: